Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Boyd

Showing results (171-180 of 257) with videos related to

Pageof 26
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1988
Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancerR H Wiltrout, M R Boyd, T C Back, et al.
Journal of Medicinal Chemistry|July 8, 1994
Anticancer specificity of some ellipticinium salts against human brain tumors in vitroE M Acton, V L Narayanan, P A Risbood, et al.
Anti-Cancer Drug Design|June 7, 2002
Antineoplastic agents 460. Synthesis of combretastatin A-2 prodrugsG R Pettit, B R Moser, M R Boyd, et al.
Journal of Natural Products|June 30, 2001
A novel anti-HIV macrocyclic peptide from Palicourea condensataH R Bokesch, L K Pannell, P K Cochran, et al.
AIDS Research and Human Retroviruses|September 1, 1990
Interactive laser cytometric analysis of retroviral protein expression in HIV-infected lymphocytic cell linesJ T Warren, J B McMahon, O S Weislow, et al.
Ciba Foundation Symposium|January 1, 1994
Ethnobotany and drug discovery: the experience of the US National Cancer InstituteG M Cragg, M R Boyd, J H Cardellina, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitorsA Hizi, R Tal, M Shaharabany, et al.
Journal of Biomolecular Screening|July 14, 2000
Development of a cyanovirin-N-HIV-1 gp120 binding assay for high throughput screening of natural product extracts by time-resolved fluorescenceJ B McMahon, J A Beutler, B R O'Keefe, et al.
Anti-Cancer Drug Design|February 25, 1998
Antineoplastic agents 360. Synthesis and cancer cell growth inhibitory studies of dolastatin 15 structural modificationsG R Pettit, E J Flahive, M R Boyd, et al.
Journal of Natural Products|November 15, 2000
Stolonic acids A and B, new cytotoxic cyclic peroxides from an Indian Ocean ascidian Stolonica speciesM T Davies-Coleman, K R Gustafson, C L Cantrell, et al.
Pageof 26

Showing results (171-180 of 257) with videos related to

Sort By:
Pageof 26
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1988
Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancerR H Wiltrout, M R Boyd, T C Back, et al.
Journal of Medicinal Chemistry|July 8, 1994
Anticancer specificity of some ellipticinium salts against human brain tumors in vitroE M Acton, V L Narayanan, P A Risbood, et al.
Anti-Cancer Drug Design|June 7, 2002
Antineoplastic agents 460. Synthesis of combretastatin A-2 prodrugsG R Pettit, B R Moser, M R Boyd, et al.
Journal of Natural Products|June 30, 2001
A novel anti-HIV macrocyclic peptide from Palicourea condensataH R Bokesch, L K Pannell, P K Cochran, et al.
AIDS Research and Human Retroviruses|September 1, 1990
Interactive laser cytometric analysis of retroviral protein expression in HIV-infected lymphocytic cell linesJ T Warren, J B McMahon, O S Weislow, et al.
Ciba Foundation Symposium|January 1, 1994
Ethnobotany and drug discovery: the experience of the US National Cancer InstituteG M Cragg, M R Boyd, J H Cardellina, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitorsA Hizi, R Tal, M Shaharabany, et al.
Journal of Biomolecular Screening|July 14, 2000
Development of a cyanovirin-N-HIV-1 gp120 binding assay for high throughput screening of natural product extracts by time-resolved fluorescenceJ B McMahon, J A Beutler, B R O'Keefe, et al.
Anti-Cancer Drug Design|February 25, 1998
Antineoplastic agents 360. Synthesis and cancer cell growth inhibitory studies of dolastatin 15 structural modificationsG R Pettit, E J Flahive, M R Boyd, et al.
Journal of Natural Products|November 15, 2000
Stolonic acids A and B, new cytotoxic cyclic peroxides from an Indian Ocean ascidian Stolonica speciesM T Davies-Coleman, K R Gustafson, C L Cantrell, et al.
Pageof 26